Antimicrobial activity and pathogen mutation prevention of originator and generics of cefepime, linezolid and piperacillin/tazobactam against clinical isolates of Staphylococcus aureus
ABSTRACT: Objectives: Although generic medicinal products are required to have the same qualitative and quantitative composition of the active substance as their reference originator product, patients and health care professionals express concerns about their interchangeability and safety. Therefor...
Main Authors: | Felix Bergmann, Alina Nussbaumer-Pröll, Beatrix Wulkersdorfer, Sabine Eberl, Werner Ruppitsch, Sarah Lepuschitz, Markus Zeitlinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716523001121 |
Similar Items
-
Comparison of Antimycotic Activity of Originator and Generics of Voriconazole and Anidulafungin against Clinical Isolates of <i>Candida albicans</i> and <i>Candida glabrata</i>
by: Alina Karoline Nussbaumer-Pröll, et al.
Published: (2022-02-01) -
Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
by: Bo-Guen Kim, et al.
Published: (2023-05-01) -
Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa
by: A. Nussbaumer-Pröll, et al.
Published: (2022-04-01) -
Use of Supplemented or Human Material to Simulate PD Behavior of Antibiotics at the Target Site In Vitro
by: Alina Nussbaumer-Pröll, et al.
Published: (2020-08-01) -
Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia
by: Laila M. Najia, et al.
Published: (2023-01-01)